Home › Interstitial Lung Diseases › Florida › Davie
Interstitial Lung Diseases clinical trials in Davie, FL
4 studies for Interstitial Lung Diseases are looking for participants at sites in and around Davie (within about 30 miles). Open a study to see who can join and how to contact the study team.
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
RecruitingPhase 3
- Cleveland Clinic Florida, Weston · 11 mi away
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- Cleveland Clinic Florida, Weston · 11 mi away
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- Weston Hospital - Cleveland Clinic Florida, Weston · 11 mi away
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RecruitingPhase 3
- Cleveland Clinic Florida, Weston · 11 mi away
About Interstitial Lung Diseases
Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.
More about Interstitial Lung Diseases on MedlinePlus
Interstitial Lung Diseases trials in other cities
- New York City, NY19 studies
- Philadelphia, PA17 studies
- Los Angeles, CA15 studies
- Kansas City, KS14 studies
- Chicago, IL13 studies
- Houston, TX13 studies
- Charleston, SC13 studies
- Durham, NC13 studies
- Ann Arbor, MI11 studies
- Aurora, CO11 studies
- Rochester, MN10 studies
- Birmingham, AL10 studies
Other studies in Davie
- Breast Cancer7 studies
- Obesity6 studies
- Overweight6 studies
- Heart Failure6 studies
- Cancer (all types)5 studies
- Type 2 Diabetes4 studies
- Amyotrophic Lateral Sclerosis4 studies
- Non-Small Cell Lung Cancer4 studies
- Cardiogenic Shock3 studies
- Cardiovascular Disease3 studies
- Renal Insufficiency3 studies
- Lupus3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.